UPDATE : Wednesday, August 5, 2020
Researchers find potential protein for brain disorder drug by Shim Hyun-tai 2020-06-12 16:37
Researchers find key for arthritis recovery by Shim Hyun-tai 2020-05-29 18:01
Immunis Bio files patent for shaking culture of immune cells by Shim Hyun-tai 2020-05-22 18:24
Daewon launches Richter-Helm Biotec’s osteoporosis biosimilar in Korea by Lee Han-soo 2020-05-18 16:00
Why did Kolon change Invossa contract manufacturer to Lonza? by Jeong Sae-im 2020-05-14 12:03
‘Helixmith’s new extract improves memory of Alzheimer’s patients’ by Shim Hyun-tai 2020-05-13 19:27
HanAll’s profit increases despite sales drop in Q1 by Lee Han-soo 2020-05-11 18:37
JW CreaGene wins European nod for new bio-drug by Shim Hyun-tai 2020-05-08 17:41
Bridge Biotherapeutics scores regulatory nod for trial of NSCLC treatment by Lee Han-soo 2020-05-08 15:45
Celltrion Healthcare launches Remsima SC in Netherlands by Lee Han-soo 2020-05-07 14:53
Cellivery sure to win licensing deal with top pharma company by Jeong Sae-im 2020-05-07 11:27
Theragen Bio starts as independent company by Shim Hyun-tai 2020-05-06 17:24
Kolon begins testing gene therapy for neuropathic pain in US by Jeong Sae-im 2020-04-27 16:18
Pharmicell’s sales to rise with commercial supply of mPEG by Shim Hyun-tai 2020-04-24 18:10
Herzuma wins 40% of market share in Japan by Shim Hyun-tai 2020-04-21 16:42
‘Stem cell therapy more effective on Covid-19’ by Jeong Sae-im 2020-04-21 11:01
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’ by Jeong Sae-im 2020-04-17 16:07
Samsung Bioepis launches anticancer biosimilar in US by Shim Hyun-tai 2020-04-16 17:32
What are the odds for successful Invossa trials in US? by Jeong Sae-im 2020-04-14 15:01
Celltrion gets antibody candidates neutralizing new coronavirus by Shim Hyun-tai 2020-04-13 18:16
Back to Top